Cargando…
Choroidal infarction following ophthalmic artery chemotherapy
BACKGROUND: Methylenetetrahydrofolate reductase (MTHFR) genetic mutations and intra-procedural inhaled nitrous oxide (N(2)O) independently increase blood levels of homocysteine, a compound associated with thrombosis. Patients with MTHFR mutations who also receive N(2)O during ophthalmic artery chemo...
Autores principales: | Bohm, Kelley J., Gobin, Y. Pierre, Francis, Jasmine H., McInerney, Gabrielle, Dabo-Trubelja, Anahita, Dalecki, Paul H., Marr, Brian P., Abramson, David H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925835/ https://www.ncbi.nlm.nih.gov/pubmed/29736261 http://dx.doi.org/10.1186/s40942-018-0119-x |
Ejemplares similares
-
Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma
por: Abramson, David H., et al.
Publicado: (2016) -
Treatment of juxtapapillary hemangioblastoma by intra-arterial (ophthalmic artery) chemotherapy with bevacizumab
por: Francis, Jasmine H., et al.
Publicado: (2018) -
Carboplatin +/− Topotecan Ophthalmic Artery Chemosurgery for Intraocular Retinoblastoma
por: Francis, Jasmine H., et al.
Publicado: (2013) -
Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC
por: Abramson, David H., et al.
Publicado: (2015) -
Combined, Sequential Intravenous and Intra-Arterial Chemotherapy (Bridge Chemotherapy) for Young Infants with Retinoblastoma
por: Gobin, Y. Pierre, et al.
Publicado: (2012)